Aditxt, Inc. Common Stock (ADTX) Stock Price

ADTXStock
$0.01100.00%52W
Market Cap$6.49M
P/E
PEG Ratio
Div yield
Beta1.30

ADTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-111.24%
Price vs S&P 500 (4W)176.95%
VGM Score35.51

ADTX Earnings Surprise History

Q4 22673.92est. -319.68
Q1 23-282.96est. -190.08
Q3 23-10534.33est. -1723.68

ADTX Analyst Recommendations

Apr 2024
May 2024
Jun 2024
Jul 2024
4.00
2.17
4.00
4.00

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ADTXAditxt, Inc. Common Stock
DCF$0.01
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Aditxt, Inc. Common Stock

Aditxt Inc is a life sciences company developing immunomodulatory therapies focused on organ transplant tolerance and autoimmune disease treatment. Its pipeline includes Adimune, AditxtScore, and ADI-100, a novel Apoptotic DNA Immunotherapy designed to induce immune tolerance to transplanted organs by mimicking the body's natural tolerance mechanisms.